tiprankstipranks
Conmed (DE:EC8)
FRANKFURT:EC8
Holding DE:EC8?
Track your performance easily

Conmed (EC8) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
1Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Conmed’s (EC8) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Conmed is a Buy.
Conmed’s (EC8) 20-Day exponential moving average is 67.84, while Conmed’s (EC8) share price is €65.5, making it a Sell.
Conmed’s (EC8) 50-Day exponential moving average is 66.66, while Conmed’s (EC8) share price is €65.5, making it a Sell.

Conmed (EC8) Pivot Points

Dec 26, 2024, 06:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
66.50
66.50
66.50
66.50
66.50
66.50
66.50
Fibonacci
66.50
66.50
66.50
66.50
66.50
66.50
66.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Conmed (EC8) Moving Averages

Dec 26, 2024, 06:08 AM
Period
Simple
Exponential
MA5
66.58Sell
66.58Sell
MA10
67.94Sell
67.39Sell
MA20
68.89Sell
67.84Sell
MA50
65.72Sell
66.66Sell
MA100
64.26Buy
65.97Sell
MA200
65.21Buy
68.42Sell
Conmed’s (EC8) 10-Day exponential moving average is 67.39, while Conmed’s (EC8) share price is €65.5, making it a Sell.
Conmed’s (EC8) 100-Day exponential moving average is 65.97, while Conmed’s (EC8) share price is €65.5, making it a Sell.
Conmed’s (EC8) stock price is €65.5 and Conmed’s (EC8) 50-day simple moving average is 65.72, creating a Sell signal.
Conmed’s (EC8) stock price is €65.5 and Conmed’s (EC8) 100-day simple moving average is 64.26, creating a Buy signal.
Conmed’s (EC8) stock price is €65.5 and Conmed’s (EC8) 200-day simple moving average is 65.21, creating a Buy signal.

Conmed (EC8) Technical Indicators

Dec 26, 2024, 06:08 AM
Name
Value
Implied Action
RSI (14)
42.04
Neutral
STOCH (9,6)
-1.61
Buy
STOCHRSI (14)
-1.17
Buy
MACD (12,26)
-0.11
Buy
ADX (14)
13.06
Buy
Williams %R
-100.00
Buy
CCI (14)
-157.95
Buy
ATR (14)
1.05
-
Ultimate Oscillator
2.25
Sell
ROC
-8.76
Sell
Conmed’s (EC8) Relative Strength Index (RSI) is 42.04, creating a Neutral signal.
Conmed’s (EC8) Trend Strength Indicator (ADX) is 13.06, creating a Buy signal.
Conmed’s (EC8) Commodity Channel Index (CCI) is -157.95, creating a Buy signal.
Conmed’s (EC8) Price Rate of Change (ROC) is -8.76, creating a Sell signal.

FAQ

Is EC8 a Buy, Hold, or Sell?
Based on EC8’s technical indicators, EC8 is a Sell.
    What is EC8’s RSI (14)?
    EC8’s RSI (14) is 42.04, which suggests EC8 is a Neutral.
      What is EC8’s MACD?
      EC8’s MACD is -0.11, which suggests EC8 is a Buy.
        What is EC8’s 5-day moving average?
        EC8’s 5-day moving average is 66.58, which suggests EC8 is a Sell.
          What is EC8’s 20-day moving average?
          EC8 20-day moving average is 68.89, which suggests EC8 is a Sell.
            What is EC8’s 50-day moving average?
            EC8’s 50-day moving average is 65.72, which suggests EC8 is a Sell.
              What is EC8’s 200-day moving average?
              EC8’s 200-day moving average is 65.21, which suggests EC8 is a Buy.
                What is EC8’s Williams % R (14)?
                EC8’s Williams % R (14) is -100.00, which suggests EC8 is a Buy.
                  What is EC8’s CCI (14)?
                  EC8’s CCI (14) is -157.95, which suggests EC8 is a Buy.
                    What is the share price of Conmed?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis